Transcriptional Control of Submucosal Gland Formation and Function
Transcriptional Control of Submucosal Gland Formation and Function
批准号:
8656410
负责人:
Jeffrey A Whitsett
金额:
$38.99万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2015-04-30
关键词:
AffectAreaAsthmaBacteriaBiologyBronchiBronchiectasisCell Differentiation processCell LineChronic Obstructive Airway DiseaseChronic lung diseaseCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataDefectDevelopmentDiseaseElectrolytesEmbryoEpithelialEpithelial CellsEscalatorFamily suidaeGene ExpressionGenesGlandGrantGrowthHealthHost DefenseHumanIn VitroIndividualInfectionInflammationLifeLiquid substanceLungLung diseasesMetaplasiaMolecularMorphogenesisMucociliary ClearanceMucous body substanceMusMutationNKX2H genePathogenesisPatternPerinatalPlayPredispositionProcessProcessed GenesProductionProteinsPulmonary Cystic FibrosisRecurrenceRegulationRegulatory PathwayResearchRespiration DisordersRespiratory SystemRespiratory physiologyRespiratory tract structureRoleSCID MiceSiteSterilityStructureSurfaceSystemTestingTracheaTranscriptional RegulationTransgenic MiceVirusWorkairway epitheliumbasecell growthdisabilityin vivomicrobialmillimetermortalityneglectnovelparticlepathogenprogenitorprogramspromoterrespiratorytoxicanttranscription factor
中文摘要
描述(由申请人提供):呼吸道持续暴露于微生物病原体和颗粒,但受到多层宿主防御系统的保护,该系统用于维持肺功能和无菌性。粘液纤毛清除、粘液产生和宿主防御的严重缺陷伴随常见的慢性肺部疾病,包括囊性纤维化(CF)、慢性阻塞性肺病和哮喘。这些疾病并发有粘液化生、粘液过度生成或粘液化、炎症和对肺部感染的易感性。本申请旨在确定CF中与肺部疾病相关的粘膜纤毛清除缺陷的分子机制。这项工作是基于初步数据,证明1)一种新的转录因子网络,决定了气道上皮细胞(AEC)内衬发育气管和支气管的图案化和分化,以及粘膜下腺体(SMG)的形成,分泌大部分液体,电解质和宿主防御蛋白到气道表面,2)图案化,生长,分化,囊性纤维化跨膜传导调节因子(Cystic Fibrosis Transmembrane Conductance Regulator,CFTR)的缺乏影响AEC和SMG的基因表达。本申请将测试PAX9和相关转录网络在发育和成熟气道中调节AEC和SMG形态发生和功能中起关键作用的假设。该提议将利用转基因小鼠,其中PAX9和与PAX9相关的基因在体内和体外条件性缺失或添加到发育和成熟的气道上皮中。PAX9和相关蛋白调节对AEC和SMG形成和功能至关重要的基因和过程的分子和细胞机制将被评估。将在CFTR缺陷的猪和小鼠中确定所提出的PAX9依赖性调节程序在CF的肺部并发症的发病机制中的作用。该建议旨在确定AEC和SMG形态发生的细胞和分子基础以及与粘膜纤毛清除缺陷引起的复发性感染的发病机制相关的功能。
英文摘要
DESCRIPTION (provided by applicant): The respiratory tract is constantly exposed to microbial pathogens and particles, but is protected by a multitiered host defense system that serves to maintain lung function and sterility. Severe defects in mucociliary clearance, mucus production, and host defense accompany common chronic lung diseases, including cystic fibrosis (CF), chronic obstructive pulmonary disease, and asthma. These disorders are complicated by mucus metaplasia, mucus hyperproduction or inspissation, inflammation, and susceptibility to pulmonary infection. This application seeks to determine the molecular mechanisms underlying deficits in mucociliary clearance associated with pulmonary disease in CF. The work is based on preliminary data demonstrating 1) a novel network of transcription factors that determines both the patterning and differentiation of airway epithelial cells (AECs) lining the developing trachea and bronchi, and the formation of submucosal glands (SMGs) that secrete the majority of fluids, electrolytes, and host defense proteins onto the airway surface and 2) that patterning, growth, diferentiation, and gene expression of AECs and SMGs are influenced by the lack of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). This application will test the hypothesis that PAX9 and an associated transcriptional network play a critical role in the regulation of AEC and SMG morphogenesis and function in the developing and mature airway. This proposal will utilize transgenic mice in which PAX9 and genes associated with PAX9 are conditionally deleted or added to the developing and mature airway epithelium in vivo and in vitro. The molecular and cellular mechanisms by which PAX9 and associated proteins regulate genes and processes critical for AEC and SMG formation and function wil be assessed. The role of the proposed PAX9-dependent regulatory program in the pathogenesis of the pulmonary complications of CF will be determined in CFTR-deficient pigs and mice. This proposal seeks to determine the cellular and molecular basis underlying AEC and SMG morphogenesis and function relevant to the pathogenesis of recurrent infections caused by defects in mucociliary clearance.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization.
通过原位杂交检测肿瘤性和非肿瘤性人肺组织中表面活性剂相关蛋白 A 和 Clara 细胞 10 kD mRNA 的表达。
DOI:
--
发表时间:
1992
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
[Broers,JL, Jensen,SM, Travis,WD, Pass,H, Whitsett,JA, Singh,G, Katyal,SL, Gazdar,AF, Minna,JD, Linnoila,RI]
通讯作者:
Linnoila,RI
LungMap Phase II - Building a multidimensional map of developing human lung
-
批准号:10000199
-
项目类别:
-
资助金额:$89.73万
-
财政年份:2019
-
负责人:Jeffrey A Whitsett
-
依托单位:
LungMap Phase II - Building a multidimensional map of developing human lung
-
批准号:10672949
-
项目类别:
-
资助金额:$89.73万
-
财政年份:2019
-
负责人:Jeffrey A Whitsett
-
依托单位:
LungMap Phase II - Building a multidimensional map of developing human lung
-
批准号:10227695
-
项目类别:
-
资助金额:$89.73万
-
财政年份:2019
-
负责人:Jeffrey A Whitsett
-
依托单位:
LungMap Phase II - Building a multidimensional map of developing human lung
-
批准号:10462002
-
项目类别:
-
资助金额:$89.73万
-
财政年份:2019
-
负责人:Jeffrey A Whitsett
-
依托单位:
Pilot and Feasibility Core
-
批准号:10477253
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2018
-
负责人:Jeffrey A Whitsett
-
依托单位:
Pilot and Feasibility Core
-
批准号:10249243
-
项目类别:
-
资助金额:$25.15万
-
财政年份:2018
-
负责人:Jeffrey A Whitsett
-
依托单位:
Pilot and Feasibility Core
-
批准号:10017688
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2018
-
负责人:Jeffrey A Whitsett
-
依托单位:
Omics of Lung Diseases
-
批准号:8574590
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2013
-
负责人:Jeffrey A Whitsett
-
依托单位:
Omics of Lung Diseases
-
批准号:8857245
-
项目类别:
-
资助金额:$26.96万
-
财政年份:2013
-
负责人:Jeffrey A Whitsett
-
依托单位:
Omics of Lung Diseases
-
批准号:9284511
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2013
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Control of Submucosal Gland Formation and Function
-
批准号:8152823
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2011
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Control of Submucosal Gland Formation and Function
-
批准号:8462293
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2011
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Control of Submucosal Gland Formation and Function
-
批准号:8294554
-
项目类别:
-
资助金额:$39.47万
-
财政年份:2011
-
负责人:Jeffrey A Whitsett
-
依托单位:
Unbiased genome-wide screen to identify genes regulating mucous cell hyperplasia
-
批准号:7822932
-
项目类别:
-
资助金额:$43.05万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:8650303
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:9057102
-
项目类别:
-
资助金额:$52.86万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:7788088
-
项目类别:
-
资助金额:$51.59万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:9246559
-
项目类别:
-
资助金额:$52.86万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:8501840
-
项目类别:
-
资助金额:$50.32万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
Transcriptional Programming of Asthma Related Pathology in Respiratory Epithelia
-
批准号:8228191
-
项目类别:
-
资助金额:$51.43万
-
财政年份:2009
-
负责人:Jeffrey A Whitsett
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: